Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Abstract 3075: Targeting endoplasmic reticulum stress pathways to combat enzalutamide resistance in prostate cancer

Amos Olalekan Akinyemi, Md Rakibul Alam, Mithu Howlader, Jianlin Wang, Lixiang Gu, Xiaoqi Liu, Zhiguo Li

Cancer Res (2025) 85 (8_Supplement_1): 3075.

https://doi.org/10.1158/1538-7445.AM2025-3075

Published: 21 April 2025

View articletitled, Abstract 3075: Targeting endoplasmic reticulum stress pathways to combat enzalutamide resistance in prostate cancer

Journal Articles

Abstract 6816: Synergistic targeting of nonsense-mediated mRNA decay and heat shock protein 90α for treating lethal prostate cancer

Jinghui Liu, Xinyi Wang, Hamed Maasoumyhaghighi, Mansoureh Nouri, Xiaoqi Liu

Cancer Res (2025) 85 (8_Supplement_1): 6816.

https://doi.org/10.1158/1538-7445.AM2025-6816

Published: 21 April 2025

View articletitled, Abstract 6816: Synergistic targeting of nonsense-mediated mRNA decay and heat shock protein 90α for treating lethal prostate cancer

Journal Articles

Abstract 1406: Plk1 attenuates colon inflammation and tumorigenesis

Xinyi Wang, Dang he, Fengyi Mao, Yifan Kong, Chaohao Li, Sai Wu, Jia Peng, Chi Wang, Zhiguo Li, Xiaoqi Liu

Cancer Res (2024) 84 (6_Supplement): 1406.

https://doi.org/10.1158/1538-7445.AM2024-1406

Published: 22 March 2024

View articletitled, Abstract 1406: Plk1 attenuates colon inflammation and tumorigenesis

Journal Articles

Abstract 3266: Plk1 promotes Pdcd4 degradation to enhance enzalutamide resistance in prostate cancer

Qing Wang, Qiongsi Zhang, Yanquan Zhang, Xiaoqi Liu, Hsin-Sheng Yang

Cancer Res (2024) 84 (6_Supplement): 3266.

https://doi.org/10.1158/1538-7445.AM2024-3266

Published: 22 March 2024

View articletitled, Abstract 3266: Plk1 promotes Pdcd4 degradation to enhance enzalutamide resistance in prostate cancer

Journal Articles

Abstract 6014: PLK1-dependent phosphorylation of PRMT5 promotes DNA damage response in prostate cancer

Jia Peng, Yanquan Zhang, Jianlin Wang, Qianjin Li, Daheng He, Xinyi Wang, Xiongjian Rao, Meng Wu, Pingli Mo, Lei Wang, Sai Wu, Ruixin Wang, Jinghui Liu, Mansoureh Nouri, Izumi Tadahide, Xiaoqi Liu

Cancer Res (2024) 84 (6_Supplement): 6014.

https://doi.org/10.1158/1538-7445.AM2024-6014

Published: 22 March 2024

View articletitled, Abstract 6014: PLK1-dependent phosphorylation of PRMT5 promotes DNA damage response in prostate cancer

Journal Articles

Abstract 3634: Overexpression of PLK1 activates IL4/JAK/STAT6 signaling in prostatic tumor-microenvironment

Ruixin Wang, Xiaoqi Liu

Cancer Res (2023) 83 (7_Supplement): 3634.

https://doi.org/10.1158/1538-7445.AM2023-3634

Published: 04 April 2023

View articletitled, Abstract 3634: Overexpression of PLK1 activates IL4/JAK/STAT6 signaling in prostatic tumor-microenvironment

Journal Articles

Abstract 2327: Novel role of NAC1 in regulating tumor stem cells and their interaction with immune cells in triple-negative breast cancer

Chrispus M. Ngule, Hami Hemati, Xingcong Ren, Emily Bachert, Xiaoqi Liu, Jin-Ming Yang

Cancer Res (2023) 83 (7_Supplement): 2327.

https://doi.org/10.1158/1538-7445.AM2023-2327

Published: 04 April 2023

View articletitled, Abstract 2327: Novel role of NAC1 in regulating tumor stem cells and their interaction with immune cells in triple-negative breast cancer

Journal Articles

Abstract 1077: Porcupine inhibition enhances enzalutamide efficacy in drug resistant prostate cancer

Katelyn Makayla Jones, Xiaoqi Liu

Cancer Res (2023) 83 (7_Supplement): 1077.

https://doi.org/10.1158/1538-7445.AM2023-1077

Published: 04 April 2023

View articletitled, Abstract 1077: Porcupine inhibition enhances enzalutamide efficacy in drug resistant prostate cancer

Journal Articles

Abstract 3673: Plk1 phosphorylation of PHGDH to regulate serine metabolism

Xiongjian Rao, Derek B. Allison, Robert M. Flight, Yuanyuan Wu, Timothy Scott, Daheng He, RuiXing Wang, Zhiguo Li, Chaohao Li, Yifan Kong, Fengyi Mao, Chi Wang, Richard M. Higashi, Andrew N. Lane, Hunter NB Moseley, Xiaoqi Liu

Cancer Res (2023) 83 (7_Supplement): 3673.

https://doi.org/10.1158/1538-7445.AM2023-3673

Published: 04 April 2023

View articletitled, Abstract 3673: Plk1 phosphorylation of PHGDH to regulate serine metabolism

Journal Articles

Abstract 3605: Peroxiredoxin IV promotes prostate cancer malignancy through the activation of NF-kB signaling

Na Ding, Hong Jiang, Pratik Thapa, Yanning Hao, Aziza Alshahrani, Vivek Rangnekar, Xiaoqi Liu, Qiou Wei

Cancer Res (2023) 83 (7_Supplement): 3605.

https://doi.org/10.1158/1538-7445.AM2023-3605

Published: 04 April 2023

View articletitled, Abstract 3605: Peroxiredoxin IV promotes prostate cancer malignancy through the activation of NF-kB signaling

Journal Articles

Abstract 4840: Dysregulation of mitochondrial function by PLK1-mediated PDHA1 phosphorylation promotes Cr(VI)-associated lung cancer progression

Qiongsi Zhang, Zhiguo Li, Xiongjian Rao, Derek B. Allison, Qi Qiao, Zhuangzhuang Zhang, Yifan Kong, Ruixin Wang, Teresa W. Fan, Richard M. Higashi, Andrew N. Lane, Xiaoqi Liu

Cancer Res (2023) 83 (7_Supplement): 4840.

https://doi.org/10.1158/1538-7445.AM2023-4840

Published: 04 April 2023

View articletitled, Abstract 4840: Dysregulation of mitochondrial function by PLK1-mediated PDHA1 phosphorylation promotes Cr(VI)-associated lung cancer progression

Journal Articles

Abstract 5508: Artesunate increases enzalutamide efficacy in advanced prostate cancer

Xinyi Wang, Fengyi Mao, Jinghui Liu, Yifan Kong, Dang he, Chi Wang, Zhiguo Li, Xiaoqi Liu

Cancer Res (2023) 83 (7_Supplement): 5508.

https://doi.org/10.1158/1538-7445.AM2023-5508

Published: 04 April 2023

View articletitled, Abstract 5508: Artesunate increases enzalutamide efficacy in advanced prostate cancer

Journal Articles

Abstract 4997: PLK1 promotes the metastasis and drug resistance in melanoma

Fengyi Mao, Yifan Kong, Chaohao Li, Yanquan Zhang, Xiongjian Rao, Qiongsi Zhang, Xinyi Wang, Zhiguo Li, Xiaoqi Liu

Cancer Res (2023) 83 (7_Supplement): 4997.

https://doi.org/10.1158/1538-7445.AM2023-4997

Published: 04 April 2023

View articletitled, Abstract 4997: PLK1 promotes the metastasis and drug resistance in melanoma

Journal Articles

Abstract 321: Metformin enhances the efficacy of enzalutamide treatment in castration-resistant prostate cancer

Kendall Elizabeth Simpson, ZhuangZhuang Zhang, Qiongsi Zhang, Xiaoqi Liu

Cancer Res (2023) 83 (7_Supplement): 321.

https://doi.org/10.1158/1538-7445.AM2023-321

Published: 04 April 2023

View articletitled, Abstract 321: Metformin enhances the efficacy of enzalutamide treatment in castration-resistant prostate cancer

Journal Articles

Abstract 4992: Taxol-elevated PLK1 overcomes BETi-resistant in prostate cancer via triggering phosphorylation-dependent degradation of BRD4

Yanquan Zhang, Ka Will Fong, Fengyi Mao, Ruixin Wang, Yifan Kong, Chaohao Li, Jinghui Liu, Zhiguo Li, Derek B. Allison, Dana Napier, Daheng Li, Jinpeng Liu, Chi Wang, Yeqing Zhang, Guangbing Li, Xiaoqi Liu

Cancer Res (2023) 83 (7_Supplement): 4992.

https://doi.org/10.1158/1538-7445.AM2023-4992

Published: 04 April 2023

View articletitled, Abstract 4992: Taxol-elevated PLK1 overcomes BETi-resistant in prostate cancer via triggering phosphorylation-dependent degradation of BRD4

Journal Articles

Abstract 3495: A kinome‐wide CRISPR screen identifies CK1α as a novel target to overcome enzalutamide resistance of prostate cancer

Jinghui Liu, Yue Zhao, Derek Allison, Daheng He, Lang Li, Xiaoqi Liu

Cancer Res (2023) 83 (7_Supplement): 3495.

https://doi.org/10.1158/1538-7445.AM2023-3495

Published: 04 April 2023

View articletitled, Abstract 3495: A kinome‐wide CRISPR screen identifies CK1α as a novel target to overcome enzalutamide resistance of prostate cancer

Journal Articles

Abstract 2578: Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via upregulation of DIO2

Chaohao Li, Daheng He, Fengyi Mao, Xinyi Wang, Yanning Hao, Yifan Kong, Christine F. Brainson, Jinghui Liu, Yanquan Zhang, Ruixin Wang, Qiongsi Zhang, Zhiguo Li, Xiongjian Rao, Sai Wu, Chi Wang, Qiou Wei, Jianlin Wang, Xiaoqi Liu

Cancer Res (2023) 83 (7_Supplement): 2578.

https://doi.org/10.1158/1538-7445.AM2023-2578

Published: 04 April 2023

View articletitled, Abstract 2578: Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via upregulation of DIO2

Journal Articles

Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint Therapy

Zhuangzhuang Zhang, Lijun Cheng, Jie Li, Qi Qiao, Anju Karki, Derek B. Allison, Nuha Shaker, Kunyu Li, Sagar M. Utturkar, Nadia M. Atallah Lanman, Xiongjian Rao, Piotr Rychahou, Daheng He, Stephen F. Konieczny, Chi Wang, Qing Shao, B. Mark Evers, Xiaoqi Liu

Cancer Res (2022) 82 (19): 3532–3548.

https://doi.org/10.1158/0008-5472.CAN-22-0018

Published: 04 October 2022

View articletitled, Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint Therapy

Includes: Supplementary data

Journal Articles

Abstract 1345: p300/CBP bromodomain inhibitor CCS1477 enhances the efficacy of immune checkpoint blockade therapy in cancer treatment

Jinghui Liu, Xinyi Wang, Katelyn Jones, Nigel Brooks, Neil Pegg, Xiaoqi Liu

Cancer Res (2022) 82 (12_Supplement): 1345.

https://doi.org/10.1158/1538-7445.AM2022-1345

Published: 15 June 2022

View articletitled, Abstract 1345: p300/CBP bromodomain inhibitor CCS1477 enhances the efficacy of immune checkpoint blockade therapy in cancer treatment

Journal Articles

MiR-644a Disrupts Oncogenic Transformation and Warburg Effect by Direct Modulation of Multiple Genes of Tumor-Promoting Pathways

Jey S. Ebron, Eswar Shankar, Jagjit Singh, Kavleen Sikand, Crystal M. Weyman, Sanjay Gupta, Daniel J. Lindner, Xiaoqi Liu, Moray J. Campbell, Girish C. Shukla

Cancer Res (2019) 79 (8): 1844–1856.

https://doi.org/10.1158/0008-5472.CAN-18-2993

Published: 15 April 2019

View articletitled, MiR-644a Disrupts Oncogenic Transformation and Warburg Effect by Direct Modulation of Multiple Genes of Tumor-Promoting Pathways

Includes: Supplementary data

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 3075: Targeting endoplasmic reticulum stress pathways to combat enzalutamide resistance in prostate cancer

Abstract 6816: Synergistic targeting of nonsense-mediated mRNA decay and heat shock protein 90α for treating lethal prostate cancer

Abstract 1406: Plk1 attenuates colon inflammation and tumorigenesis

Abstract 3266: Plk1 promotes Pdcd4 degradation to enhance enzalutamide resistance in prostate cancer

Abstract 6014: PLK1-dependent phosphorylation of PRMT5 promotes DNA damage response in prostate cancer

Abstract 3634: Overexpression of PLK1 activates IL4/JAK/STAT6 signaling in prostatic tumor-microenvironment

Abstract 2327: Novel role of NAC1 in regulating tumor stem cells and their interaction with immune cells in triple-negative breast cancer

Abstract 1077: Porcupine inhibition enhances enzalutamide efficacy in drug resistant prostate cancer

Abstract 3673: Plk1 phosphorylation of PHGDH to regulate serine metabolism

Abstract 3605: Peroxiredoxin IV promotes prostate cancer malignancy through the activation of NF-kB signaling

Abstract 4840: Dysregulation of mitochondrial function by PLK1-mediated PDHA1 phosphorylation promotes Cr(VI)-associated lung cancer progression

Abstract 5508: Artesunate increases enzalutamide efficacy in advanced prostate cancer

Abstract 4997: PLK1 promotes the metastasis and drug resistance in melanoma

Abstract 321: Metformin enhances the efficacy of enzalutamide treatment in castration-resistant prostate cancer

Abstract 4992: Taxol-elevated PLK1 overcomes BETi-resistant in prostate cancer via triggering phosphorylation-dependent degradation of BRD4

Abstract 3495: A kinome‐wide CRISPR screen identifies CK1α as a novel target to overcome enzalutamide resistance of prostate cancer

Abstract 2578: Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via upregulation of DIO2

Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint Therapy

Abstract 1345: p300/CBP bromodomain inhibitor CCS1477 enhances the efficacy of immune checkpoint blockade therapy in cancer treatment

MiR-644a Disrupts Oncogenic Transformation and Warburg Effect by Direct Modulation of Multiple Genes of Tumor-Promoting Pathways

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only